In particular, it has been reported an increased number of serum and plasma EVs in HL and NHL patients compared to healthy subjects [15, 62], and higher level of CD30+ and CD19+MVs in 11 HL and 10 NHL patients with respect to controls, respectively [15]. Here, CD19 is linked to non-Hodgkin lymphoma.